Patients in both treatment groups also received training to help them better manage their diabetes.
两组病人都接受了相关训练以帮助他们更好的控制糖尿病。
Results: No significant difference of pain scores (BCS) and incidence of AEs between both treatment groups was found.
结果:氟比洛芬酯组与曲马多组术后BCS评分及不良反应发生率无统计学差异。
Both treatment groups showed no differences at start of treatment and reported severe pain, pelvic tenderness and pelvic indurations.
在实验开始时,两个实验组没有任何差距,都有强烈的疼痛感、骨盆敏感以及骨盆硬化。
应用推荐